Status:
COMPLETED
Retrieval-Based Word Learning in Developmental Language Disorder: Verb Learning
Lead Sponsor:
Purdue University
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Developmental Language Disorder
Specific Language Impairment
Eligibility:
All Genders
48-71 years
Phase:
NA
Brief Summary
Children with developmental language disorder (DLD; also referred to as specific language impairment) experience a significant deficit in language ability that is longstanding and harmful to the child...
Detailed Description
Developmental Language Disorder (DLD) affects language learning in an estimated 7% of children. Although much of the research literature has emphasized difficulties learning grammar, children with DLD...
Eligibility Criteria
Inclusion
- a significant deficit in language ability (language test score below cutoff for best sensitivity/specificity) or documented age-appropriate language ability.
- normal hearing no evidence of neurological damage or disease scores on tests of nonverbal intelligence above the intellectual disability range not within Autistic range on Autism screening test native English speaker (can be bilingual)
Exclusion
- failed hearing screening known neurological damage or disease scores on tests of nonverbal intelligence below the intellectual disability range (standard score less than 75) autism spectrum disorder non-native English speaker
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 25 2024
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT06001866
Start Date
March 1 2023
End Date
January 25 2024
Last Update
August 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Purdue University
West Lafayette, Indiana, United States, 47907